Ruderman, Irene
Hewitson, Tim D.
Smith, Edward R.
Holt, Stephen G.
Wigg, Belinda
Toussaint, Nigel D.
Article History
Received: 30 January 2020
Accepted: 5 July 2020
First Online: 16 July 2020
Ethics approval and consent to participate
: Research performed in accordance with the Declaration of Helsinki. The study was approved by the Melbourne Health Human Research Ethics Committee (#HREC 2017.023). Written informed consent was obtained for all study participants.
: Not applicable to current manuscript.
: ERS has received research funding from Sanofi, Baxter, and Amgen and holds stock in Calciscon AG, which specializes in performing the T<sub>50</sub>-test.SGH has received research funding, teaching and travel support from Astra-Zenica, Amgen, Baxter, Sanofi.NDT has received honoraria, travel support and research funding from Amgen, Shire and Sanofi. TDH, BW and IR declare that they have no competing interests.